Cost-Effective Probiotic Phage Therapy for Psoriasis Relief
Probiotic Compositions Containing Bacteriophage to Treat or Prevent Psoriasis
Tags: The University of Hong Kong, Hong Kong, Healthcare & Lifesciences, Consumer Goods & Services
This HKU technology uses bacteriophage-enriched probiotics to treat or prevent psoriasis by restoring the skin's microbiome balance. It identifies specific phages, such as Acinetobacter phage Presley and Pseudomonas phage O4, that suppress harmful bacteria associated with psoriatic lesions. Applications include topical therapies and skincare products targeting chronic skin conditions. The innovation reduces reliance on antibiotics, addressing antimicrobial resistance, while offering a cost-effective alternative to expensive treatments. Patents are filed under PCT, ensuring proprietary protection for this novel therapeutic approach.
IP Type or Form Factor: Patent Pending; Process & Method; Material
TRL: 3 - proof of concept with needs validated
Industry or Tech Area: Biotechnology; Beauty & Aesthetics
